News Summary
Valencia Technologies, a medical device firm from California, has obtained a $35 million investment led by Brooks Advisory Group. This funding aims to support the commercialization of the eCoin® system, a groundbreaking treatment for urgency urinary incontinence (UUI). Newly appointed CEO James D. Surek brings vast experience to the team, enhancing the company’s growth potential. The FDA-approved eCoin device, a minimally invasive neurostimulator, has shown significant promise in reducing UUI episodes. With strategic guidance from Brooks Advisory, Valencia plans to effectively bring this innovative solution to market.
California – Valencia Technologies, a privately owned medical device firm based in Valencia, California, has secured a strategic investment of up to $35 million to support the commercialization of its key product, the eCoin® system, designed for treating urgency urinary incontinence (UUI). The investment is funded by Brooks Advisory Group, part of the Brooks Management Group (BMG), marking a significant step forward for the company as it aims for accelerated growth in the neuromodulation market.
The newly appointed CEO, James D. Surek, brings extensive experience in the medical device sector, having a proven track record in driving revenue growth and successful product launches. This leadership change is anticipated to play a critical role in the company’s ambitious plans, which notably include extensive commercialization activities for the eCoin system.
The eCoin device is a coin-sized neurostimulator that is implanted under the skin near the ankle through a minimally invasive outpatient procedure. Once implanted, it delivers periodic stimulation to the tibial nerve, which has shown to significantly reduce urge urinary incontinence episodes by at least 50% in approximately 75% of patients one year post-implantation. The FDA approved the eCoin system in 2022, making it the first and only FDA-approved subcutaneous implantable tibial nerve stimulator for UUI.
Under the new leadership and investment framework, the Brooks Advisory Group will also extend consulting services to Valencia Technologies, focusing on commercialization, sales, reimbursement strategies, and financial planning. This multifaceted support is expected to enhance Valencia’s ability to bring the eCoin system to market effectively and address the growing demand for less invasive treatment options in urology.
The management team is further strengthened by the inclusion of Dain Black, Ryan Brooks, and Jim Surek, who will work alongside existing board members Jeff Greiner and Don Hubbard. Surek’s previous leadership roles include a notable tenure at Advanced Bionics, where he played a pivotal role in driving revenue growth exceeding $200 million in just three years. Advanced Bionics was later acquired by Boston Scientific for around $3 billion. In another of his successes, Surek led a transformative turnaround at Entellus Medical, growing its revenue from less than $1 million to over $70 million and achieving an initial public offering (IPO) within four years.
The eCoin device not only offers a significant advantage in treating UUI but also simplifies the post-implant experience for patients. It requires minimal follow-up programming sessions and eliminates the need for weekly recharging, making it a user-friendly alternative to traditional medications and more invasive treatments.
Healthcare professionals, including specialists from Stony Brook Medicine, have praised the eCoin system for its effectiveness as a treatment option for patients enduring the challenges of overactive bladder. The device’s innovative approach could potentially reshape the landscape of UUI treatment by providing an effective, minimally invasive solution.
The substantial investment and leadership transition at Valencia Technologies represents a promising future for the company as it embarks on a mission to offer patients better solutions for managing urgency urinary incontinence through groundbreaking technology.
Deeper Dive: News & Info About This Topic
- PR Newswire: Valencia Technologies Announces Strategic Investment
- Wikipedia: Urinary Incontinence
- LA Business Journal: Avita Gets FDA Nod for Device
- Google Search: Neuromodulation
- Fortune: AI Integration at Novartis
- Google Scholar: Medical Devices
- Forbes: Singapore Billionaire’s Son Appointed President
- Encyclopedia Britannica: Medical Device
- Chicago Business: Who’s Who
- Google News: Medical Technology
Author: STAFF HERE HOLLYWOOD
The Hollywood Staff Writer represents the experienced team at HEREHollywood.com, your go-to source for actionable local news and information in Hollywood, Los Angeles County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the Hollywood Bowl summer concerts, the Hollywood Christmas Parade, film premieres at TCL Chinese Theatre, and festivals at the Magic Castle. Our coverage extends to key organizations like the Hollywood Chamber of Commerce and Visit Hollywood, plus leading businesses in entertainment, dining, and tourism that define the local economy. As part of the broader HERE network, including HERELosAngeles.com, HEREBeverlyHills.com, HEREAnaheim.com, and HEREHuntingtonBeach.com, we provide comprehensive, credible insights into Southern California's dynamic landscape.
